SCHEMBL6840149

SCHEMBL6840149

CN(C)CCn1c(-c2ccc[nH]2)nc2c(C(F)(F)F)nc3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 5/20 0.38
TERT O14746 1/20 0.35
PIM3 Q86V86 3/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
HTR6 P50406 1/20 0.33
ALDH1A1 P00352 5/20 0.32
LMNA P02545 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
GAA P10253 1/20 0.32
KDM4E B2RXH2 4/20 0.32
HPGD P15428 4/20 0.32
HSD17B10 Q99714 4/20 0.32
ALOX15 P16050 3/20 0.32
CYP3A4 P08684 3/20 0.32
TSHR P16473 3/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833754 0.87 TLR7 (0.34) PIM3MAPTTLR7KDM4E
SCHEMBL6837765 0.86 CYP2C9 (0.36) MAPTHTTALDH1A1LMNACYP3A4
SCHEMBL6840083 0.85 ALDH1A1 (0.43) TOP2AALDH1A1TLR7KDM4EHPGD
Fumaric Acid SCHEMBL6833836 0.83 CYP2C9 (0.34) MAPTHTTALDH1A1LMNACYP3A4
Fumaric Acid SCHEMBL6833838 0.83 CYP2C9 (0.34) MAPTHTTALDH1A1LMNACYP3A4
SCHEMBL6834043 0.82 ADRB2 (0.37) HTR6ALDH1A1GAAKDM4ETSHR
SCHEMBL6837643 0.82 ACP1 (0.38) TLR7
SCHEMBL6838715 0.81 ACP1 (0.37) TLR7
SCHEMBL6837751 0.81 CYP3A4 (0.37) MAPTHTTRXFP1ALDH1A1LMNA
SCHEMBL6833994 0.79 CYP3A4 (0.35) MAPTHTTALDH1A1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 TOP2A 2009/4885TERT 2388/4885PIM3 590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.